a r t I C l e S Activation of canonical Wnt signaling results in the stabilization of β-catenin and its translocation to the nucleus to associate with TCF family transcriptional protein partners. In the intestine, low-activity signaling mediated by TCF4-β-catenin is necessary for normal turnover of the epithelium throughout life and the maintenance of LGR5 + crypt stem cells 1 . A fine balance exists in the colon between Wnt pathway activation and inhibition in the determination of this lowactivity state, and numerous control mechanisms therefore exist to limit Wnt signaling levels 2 . Germline mutation of APC causes familial predisposition to colon cancer 3 . In the absence of APC, failure to degrade β-catenin results in unrestricted Wnt signaling, which reaches a threshold to elicit expression of LEF1 (ref. 4 ). This state of high LEF1-β-catenin activity drives uncontrolled epithelial growth and colon adenocarcinoma 5, 6 . Similar low versus high Wnt signaling states also distinguish normal hematopoiesis from leukemias with mutations in Wnt pathway repressor genes 7 . Many other markers have been identified from expression profiling that distinguish colon cancer from normal intestinal stem cell populations 3 . Some of these factors have been shown to function as suppressors of the Wnt pathway, such as Rnf43, an E3 ligase that ubiquitinates frizzled receptors 8 . Although in principle such markers might be useful in detecting a high-activity state in a variety of human diseases, it has yet to be shown whether pathological Wnt signaling can be achieved in non-genetically based conditions.
Oligodendrocytes are the myelinating cells of the CNS and are cellular targets of injury in human diseases such as multiple sclerosis 9 and neonatal white matter injury (WMI) leading to cerebral palsy (CP) 10, 11 . Pathological analysis of these demyelinated lesions has revealed the presence of OPCs arrested at an immature or premyelinating stage [12] [13] [14] . As remyelination of experimental rodent demyelinated lesions is reproducibly efficient, why do human lesions fail to myelinate? This question prompted us to investigate whether a high pathological Wnt tone could be demonstrated in human neonatal subcortical white matter affected by hypoxic ischemic encephalopathy (HIE) despite the fact that this is an injury-induced, non-genetic condition.
RESULTS

Common markers of high Wnt tone across diverse tissue types
Although Wnt signaling can delay the timing of OPC differentiation [15] [16] [17] [18] , it is unclear whether signaling can achieve pathological high levels to account for fixed demyelinated lesions in human injury. Indeed, the notion of a high-activity Wnt signaling state in human WMI or other non-genetic disorders has not been investigated. To define markers for high Wnt signaling across various tissues, we first compared mRNA transcripts upregulated in mouse Wnt-activated OPCs (from Olig2cre/DA-Cat mice, in which Olig2-cre is used to conditionally express floxed dominant-active β-catenin 15 ) and human colon carcinomas that are commonly driven by mutations of the Wnt pathway, such as loss of APC function 2,3 ( Supplementary Table 1 ). This analysis revealed over 47 genes with significant upregulation ( Supplementary Table 1 ). We reasoned that such information might identify both previously unknown targets of the Wnt pathway in colon cancer and new high-activity pathway markers in OPCs (Fig. 1a) . We focused on LEF1, SP5, RNF43, DUSP4 and ETS2 based on the following criteria: (i) upregulation associated with high-activity Wnt a r t I C l e S signaling in other studies, (ii) known functions in colon cancer and (iii) markers available for immunohistochemistry analysis in human and rodent samples. All five markers were expressed in adenocarcinoma ( Fig. 1b) . DUSP4, a MAP kinase phosphatase protein, has not been reported previously as a Wnt-activated target; thus, our approach served as a gene discovery tool.
High-activity Wnt elicits Lef1 and OPC maturation arrest
In the adult mammalian CNS, APC expression is specific to OPCs after cell cycle exit and mature oligodendrocytes ( Supplementary  Fig. 1 ). We generated Olig2-cre Apc flox/flox mice, which resulted in ~85% efficiency of Apc protein loss in OPCs and ~15% 'escapees' that failed to delete Apc (Supplementary Fig. 2 ). Although the numbers of OPCs were normal in the brain and spinal cord ( Supplementary  Fig. 2b) , Apc-deficient OPCs showed irreversible maturation arrest and failed to express myelin regulatory factor ( Fig. 2a) 19 or the mature oligodendrocyte markers Cnp, Mag ( Fig. 2a) , Mal, Plp and Fa2h (Supplementary Figs. 2b and 3b) . Apc-deficient OPCs expressed greatly elevated levels of the Wnt transcriptional target Axin2 ( Fig. 2b and Supplementary Fig. 4 ). Only the escapees of Olig2-cre activity that expressed Apc were capable of differentiation to Nogo-A-positive mature oligodendrocytes ( Supplementary Fig. 3a) .
High-activity Wnt signaling in colon cancer reaches a threshold to elicit the expression of LEF1, a reported target of the Wnt pathway, and involves a subsequent switch from a TCF4-β-catenin complex to a LEF1-β-catenin complex 4 ( Fig. 3a) . Once activated, LEF1 participates in a feed-forward loop that drives its own expression, which is critical for the high-activity state. Lef1 is not expressed during normal oligodendrocyte development (Fig. 3b) ; however, we observed robust Lef1 expression in the corpus callosum and spinal cord of Olig2-cre Apc flox/flox animals, suggesting that a high Wnt signaling threshold had been reached. Such Apc-deficient OPCs expressed high levels of Axin2 and remained permanently undifferentiated ( Fig. 2b and Supplementary Fig. 5 ), which is in keeping with other recent findings 20 . Conversely, Axin2 expression was undetectable in Apc-intact, Tcf4-positive OPCs (Fig. 3b) . Notably, Apc-deficient OPCs express the high-activity markers Sp5, Dusp4 and Ets2 (Fig. 4a,b ). However, unlike Wnt-driven cancers of the gut and hematopoietic systems, which respond to mitogenic Wnt signaling, we did not observe hyperproliferation of OPCs or glioma ( Supplementary Fig. 6 ). In summary, high Wnt tone in OPCs is marked by the expression of Lef1 and acts purely to block differentiation ( Fig. 3a) .
Sp5 is a Wnt target that inhibits myelin gene expression
We investigated Sp5, encoding a zinc finger type transcription factor of the SP/KLF family, which was the most highly upregulated transcription factor in Wnt-activated OPCs. We first asked whether Sp5 was a direct Wnt target. Tcf4 binds to consensus binding sites at the Sp5 locus in OPCs, as shown by chromatin immunoprecipitation (ChIP) ( Fig. 5a) . We observed Sp5 luciferase reporter gene activation in the presence of β-catenin and endogenous Tcf4 in OPCs, which was inhibited by dominant-negative Tcf4 (Fig. 5b) . The related factor Sp1 binds npg a r t I C l e S to the Mbp (encoding myelin basic protein) enhancer to activate expression 21 . Sp5 bound multiple myelin gene loci directly in OPCs but not mature oligodendrocytes, whereas the converse was true for Sp1, which showed preferential binding at myelin genes in mature oligodendrocytes ( Fig. 5d and Supplementary  Fig. 7 ). Sp5 expression inhibited baseline Mbp levels, whereas Sp1 induced activation of Mbp enhancer activity (Fig. 5c) . These findings indicate direct activation of Sp5 by Wnt signaling within OPCs and that Sp5 proteins inhibit myelin gene expression through competition with Sp1.
Sp5-null animals are viable without known gut or white matter abnormalities 22 . Consistent with this, we found that oligodendrocyte development proceeds normally in Sp5 −/− animals ( Fig. 5e and Supplementary Fig. 8 ). We next used focal injection of lysolecithin into adult spinal cord white matter to assess the kinetics of remyelination. Compared to low Sp5 expression levels in developing wild-type (WT) OPCs, we observed increased Sp5 expression levels in OPCs during remyelination ( Fig. 5f) . Strikingly, Sp5 −/− animals showed acceleration of OPC differentiation during remyelination and precocious expression of the myelin genes Mag, Cnp, Fa2h, Mbp and Plp at 7 days post-lesioning (dpl) (Fig. 5f,g and Supplementary Fig. 9 ). These findings indicate that Sp5 is a direct target of Wnt and is the first transcription factor to be identified whose function is required to delay the kinetics of normal remyelination. Further, they suggest that remyelination achieves an intermediate Wnt signaling state characterized by increased expression of Sp5 and a requirement for Sp5 function.
Human WMI OPCs express genes in common with colon cancer Subcortical WMI occurs in term infants that suffer severe HIE ( Fig. 6) . a r t I C l e S markers of high-activity Wnt signaling (i.e., LEF1, SP5, ETS2, DUSP4 and RNF43) ( Fig. 6b-d,g) . Surprisingly, such OPCs (OLIG2 + NKX2.2 + ) that coexpressed LEF1 and SP5 (Fig. 6c,d) in these lesions were uniformly APC negative (n = 300 LEF1 + cells, three independent HIE cases) ( Fig. 6e ), suggesting deficient Wnt repressor tone. Indeed, RNF43 was expressed in cells with the simple bipolar morphology of OPCs in neonatal WMI ( Fig. 6f) and in a chronic white matter lesion from a 12-year-old child with CP ( Fig. 6h) , which is consistent with the possibility of a long-standing high-activity Wnt signaling state. npg a r t I C l e S Wnt repressor loss determines switch to high-activity signaling Given these findings, we further investigated the function of Wnt repressor tone during remyelination and compared Lef1 expression in mice that were WT, Axin2 −/− or Olig2-cre Apc flox/flox (Fig. 7a) . As Axin2 is a direct target of the Wnt pathway (Fig. 2b) , Axin2 −/− mice also have a hyperactive Wnt tone, as the Axin2 protein is a known repressor of the pathway through functions in the β-catenin degradation complex 16, 23 . In the lysolecithin gliotoxic model, white matter oligodendrocytes are initially killed off and must be replaced by newly generated OPCs. As expected, based on the findings from our developmental analyses (Fig. 2) , Apc-null oligodendrocytes showed a permanent block in remyelination with persistence of Lef1 and Axin2 expression for as long as 90 dpl ( Fig. 7c and Supplementary Fig. 10) . Moreover, we observed that the numbers of Lef1 + cells were increased in lesions in an inverse manner to Wnt repressor tone ( Fig. 7b) , suggesting that the percentage of Lef1 + Olig2 + OPCs comprises an index of Wnt activity levels.
To assess whether Wnt repressor function regulates neonatal WMI, we tested the effects of mild and chronic neonatal hypoxemia (10% fraction of inspired oxygen (FiO 2 ), postnatal day (P) 3-7) on white matter volume throughout the brain. In WT mice, this treatment causes only transient delay of myelination at P11 (data not shown) with full recovery of white matter volume by P40 (Fig. 7d,e ). In contrast, Axin2 −/− mice demonstrated selective white matter volume deficits, whereas gray matter volume was not significantly affected. Together these findings suggest that deficient Wnt repressor tone and hypoxia are sufficient for permanent effects on white matter.
DISCUSSION
Pathological Wnt signaling in cancers of the colon and blood are associated with a high-activity state in genetically predisposed cells. We demonstrate that various Wnt pathway activity states can exist in the oligodendrocyte lineage and distinguish the normal process of myelination from pathological OPC differentiation block in a dose-dependent fashion. We show that developing OPCs require Apc function to prevent transition to a high-activity Wnt signaling state that permanently blocks their differentiation. Considering the requirement for APC in both colonic stem cells and OPCs, it is possible that individuals with familial adenomatous polyposis syndrome, who carry heterozygous loss-of-function mutations in APC and who are reported to suffer from intellectual disability 24 , might be prone to WMI. OPCs with high-activity Wnt signaling express many known markers in common with colon cancer, including Lef1, Sp5, Ets2 and Rnf43 (refs. 4,8,25,26) , as well as Dusp4, which we identified here. Further studies will be needed to define the tissuespecific functions of such putative pathway components downstream of Wnt signaling in OPCs. As one example, we found that Sp5 is a direct target of Tcf4, which acts in a competitive balance with the related transcription factor Sp1 for binding at mature myelin gene loci, and is essential to inhibit the kinetics of OPC differentiation after demyelinating injury.
Akin to in the colon, high-activity Wnt signaling in OPCs reaches the threshold to induce the expression of Lef1, with a subsequent switch from a TCF4-β-catenin complex to a LEF1-β-catenindependent complex. We show that remyelination in a simple mouse model and WT genetic background does not result in high-activity Wnt signaling, as we did not observe Lef1-expressing OPCs. We also did not observe Lef1 expression when other factors such as hypoxia or lipopolysaccharide-induced inflammation were added to gliotoxic npg a r t I C l e S injury ( Fig. 7a and data not shown). In contrast, OPCs that carry heterozygous or homozygous mutations of Axin2 or Apc repressor genes show Lef1 expression in OPCs in a dose-dependent manner. Thus, Wnt repressor tone is the critical factor that regulates transition to a high-activity state after injury. Indeed, Axin2 −/− mice subjected to mild hypoxia develop fixed deficits in white matter volume at P40, in marked contrast to WT controls that show no injury whatsoever. Genetic alterations in Wnt pathway repressors lead to certain cancers as well as non-cancerous pathology (e.g., bone hypertrophy) 27 . Surprisingly, we found that OPCs in human neonatal HIE (i.e., a nongenetic lesion) expressed high-activity markers similar to those in colon cancer, suggesting a parallel state of pathological Wnt signaling. This pathological Wnt tone in OPCs in human HIE goes some way to explaining why human lesions may fail to myelinate. However, further investigation will be needed to determine how this high-activity state is achieved. One possibility is that hypoxic and/or inflammatory factors result in epigenetic dysregulation of Wnt repressor tone. In this regard, it is noteworthy that OPCs with high Wnt tone consistently lacked APC expression. APC might be regulated at the transcriptional, translational level 28 or could be mislocalized within OPCs 29 in the setting of injury. For example, hypoxia in colon cancer cell lines affects APC levels through a direct effect of hypoxia-inducible factors at the APC promoter 30 . Several previous studies have also indicated that epigenetic silencing of Wnt repressors in certain colon cancers may contribute to disease progression 31, 32 , which could represent a precancerous 'kindling state' that selects for somatic mutations. Further research will be needed to establish the epigenetic mechanisms that mitigate against Wnt repressor tone in human WMI and the extent to which a high-activity Wnt signaling state exists in other non-genetically based human diseases.
METHODS
Methods and any associated references are available in the online version of the paper. Olig2 Lef1 
